MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis

Respirology

Volumn 20, Issue 3, 2015, Pages 439-444

  Horimasu, Yasushi ^a   Ohshimo, Shinichiro ^a   Bonella, Francesco ^b   Tanaka, Sonosuke ^a   Ishikawa, Nobuhisa ^a   Hattori, Noboru ^a   Kohno, Nobuoki ^a   Guzman, Josune ^c   Costabel, Ulrich ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

genetic; interstitial lung disease; lung fibrosis; single nucleotide polymorphism

Indexed keywords

MUCIN 5B; DNA; MUC5B PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; ASSAY; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FIBROSING ALVEOLITIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERMAN (CITIZEN); HUMAN; INTERSTITIAL PNEUMONIA; JAPANESE (PEOPLE); LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; GENETICS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; JAPAN; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MUCIN-5B; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84924569235     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12466     Document Type: Article

References (27)

1. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK,. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 2009; 84: 52-59.
2. Thomas AQ, Lane K, Phillips J 3rd, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 2002; 165: 1322-1328.
3. Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T, Taniguchi H, Kubo M, Kamatani N, Nakamura Y, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654-656.
4. Hodgson U, Pulkkinen V, Dixon M, Peyrard-Janvid M, Rehn M, Lahermo P, Ollikainen V, Salmenkivi K, Kinnula V, Kere J, et al. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am. J. Hum. Genet. 2006; 79: 149-154.
5. Checa M, Ruiz V, Montaño M, Velázquez-Cruz R, Selman M, Pardo A,. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465-472.
6. Ahn MH, Park BL, Lee SH, Park SW, Park JS, Kim DJ, Jang AS, Park JS, Shin HK, Uh ST, et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir. Res. 2011; 12: 73.
7. Martinelli M, Pacilli AM, Rivetti S, Lauriola M, Fasano L, Carbonara P, Mattei G, Valentini I, Scapoli L, Solmi R,. A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. Mol. Biol. Rep. 2011; 38: 4613-4617.
8. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503-1512.
9. Zhang Y, Noth I, Garcia JG, Kaminski N,. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576-1577.
10. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax 2013; 68: 436-441.
11. Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 2013; 309: 2232-2239.
12. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, Nishino M, Araki T, Zazueta OE, Kurugol S, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N. Engl. J. Med. 2013; 368: 2192-2200.
13. Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS ONE 2013; 8: e70621.
14. Horimasu Y, Hattori N, Ishikawa N, Kawase S, Tanaka S, Yoshioka K, Yokoyama A, Kohno N, Bonella F, Guzman J, et al. Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels. Respir. Med. 2012; 106: 1756-1764.
15. Horimasu Y, Hattori N, Ishikawa N, Tanaka S, Bonella F, Ohshimo S, Guzman J, Costabel U, Kohno N,. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms. BMC Med. Genet. 2014; 15: 4.
16. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
17. Kanehara M, Yokoyama A, Tomoda Y, Shiota N, Iwamoto H, Ishikawa N, Taooka Y, Haruta Y, Hattori N, Kohno N,. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. 2008; 21: 874-878.
18. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, Hattori N, Hara H, Kohno N,. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am. J. Respir. Crit. Care Med. 2009; 179: 35-40.
19. Yamane T, Hattori N, Kitahara Y, Haruta Y, Sasaki H, Yokoyama A, Kohno N,. Productive cough is an independent risk factor for the development of COPD in former smokers. Respirology 2010; 15: 313-318.
20. Ishikawa N, Hattori N, Tanaka S, Horimasu Y, Haruta Y, Yokoyama A, Kohno N, Kinnula VL,. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis. Respiration 2011; 82: 10-18.
21. Standardization of Spirometry. 1994 update. American Thoracic Society. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-1136.
22. Hiyama E, Yokohama T, Hiyama K, Yamakido M, Santo T, Kodama T, Ichikawa T, Matsuura Y,. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. J. Oncol. 1995; 6: 13-16.
23. Rubin BK,. Physiology of airway mucus clearance. Respir. Care 2002; 47: 761-768.
24. Wang C, Zhuang Y, Guo W, Cao L, Zhang H, Xu L, Fan Y, Zhang D, Wang Y,. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. PLoS ONE 2014; 9: e104919.
25. National Center for Biotechnology Information. Build 142: NCBI dbSNP, 2014. http://www.ncbi.nlm.nih.gov/snp. Accessed: 20 October 2014.
26. Peljto AL, Steele MP, Fingerlin TE, Hinchcliff ME, Murphy E, Podlusky S, Carns M, Schwarz M, Varga J, Schwartz DA,. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest 2012; 142: 1584-1588.
27. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM,. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165: 1581-1586.